Clinical Trials Directory

Trials / Unknown

UnknownNCT04104282

the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.

the Role of plin5 in the Development of a Sequence Polymorphism in Patatin-like Phospholipid Domain Containing Protein 3 Polymorphism-associated Nonalcoholic Fatty Liver Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To further clarify the role of sequence polymorphism in patatin-like phospholipid domain containing protein 3 in the development of nonalcoholic fatty liver disease.

Detailed description

A sequence polymorphism in patatin-like phospholipid domain containing protein 3 is significantly associated with nonalcoholic fatty liver disease, but its mechanism underlying this association remains obscure. We introduce the human samples of liver to clarify the relationship between the expression of plin5 and the development of sequence polymorphism in patatin-like phospholipid domain containing protein 3 variant-associated nonalcoholic fatty liver disease, analyze the lipid metabolism and lipotoxicity of hepatocytes to elucidate the mechanisms of plin5 in the development of sequence polymorphism in patatin-like phospholipid domain containing protein 3 variant-associated nonalcoholic fatty liver disease. Our study will contribute to the mechanism of nonalcoholic fatty liver disease, and its prevention and therapy.

Conditions

Timeline

Start date
2016-12-01
Primary completion
2025-12-27
Completion
2025-12-27
First posted
2019-09-26
Last updated
2024-09-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04104282. Inclusion in this directory is not an endorsement.